Alnylam and Inceptive have reached a strategic AI collaboration to accelerate the development of RNAi therapy On June 3, 2026, Alnylam Pharmaceuticals (NASDAQ: ALNY) and lnceptive Nucleics, a company dedicated to building life science foundation models, announced today that they have signed a strategic partnership agreement aimed at accelerating the development of innovative therapeutic drugs
Personal Consultation Patients will meet Dr
Neuroscientist and podcaster Andrew Huberman has described them as a new kind of wedge in between supplements and prescription pills. GQ called them the hottest thing on the fringes of fitness and anti-aging.Many are looking to peptides, a confusingly wide-ranging group of compounds, for a fitness and longevity edge
Ozempic, Wegovy, and Mounjaro: The Truth About GLP-1s for Weight and Metabolic Health GLP-1 medications like Ozempic, Wegovy, and Mounjaro have become one of the most talked-about tools in weight and metabolic health, often surrounded by social media hype, celebrity headlines, and fear-based terms like Ozempic face. But when you move past the noise and look at the science, GLP-1s are not miracle drugs or moral judgments
Understanding your individual metabolic response and genetic factors before treatment begins helps inform safer discontinuation planning